Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

DNV qualifies Aker Carbon Capture’s Just Catch Offshore™: ready to cut emissions from oil and gas production

The Just Catch Offshore™, a modularized carbon capture facility for offshore installations, has been successfully qualified by DNV, the global independent energy expert and assurance provider. It is now ready to be deployed in offshore oil and gas fields where Aker Carbon Capture’s proprietary solution can significantly reduce emissions from offshore power generation.“DNV’s recently published Energy Transition Outlook report reveals that Carbon Capture and Storage (CCS) is indispensable for global decarbonization efforts, across multiple industry sectors. We are pleased to provide

Neuraxpharm steps into the Digital Health market with a wearable device developed by mjn-neuro that provides an early warning of epileptic seizures

The CNS specialist Neuraxpharm has signed a commercialisation agreement with mjn-neuro with exclusivity in Europe Düsseldorf and Barcelona / Blanes, Girona, October 25, 2022 - Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), and mjn-neuro, a start-up that designs, manufactures and markets medical devices, today announce the signing of a commercialisation agreement for mjn-SERAS, a wearable medical device that aims to predict the risk of having an epileptic seizure.With this agreement, Neuraxpharm increases

Covid-19 dominates among the world’s 10 largest vaccine companies

The global Covid-19 pandemic has changed many aspects of our society. This is especially true in the medical world, where the new vaccines have completely overturned the prevailing hierarchy among the world’s vaccine manufacturers. Today the four largest vaccine manufacturing companies are Covid-19 vaccine manufacturers.Read the full article at biostock.se: https://www.biostock.se/en/2022/10/covid-19-dominates-among-the-worlds-10-largest-vaccine-companies/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Photocure ASA: Invitation to presentation of third quarter 2022 financial results

Oslo, Norway, 25 October 2022: Photocure ASA (Photocure, PHO: OSE) will announce the third quarter 2022 financial results on Wednesday 2 November 2022 at 08:00 CEST and will present a live webcast at 14:00 CEST the same day.The quarterly report and presentation will be published at 08:00 CEST and will be publicly available at www.photocure.com. The investor presentation will be streamed live and be hosted by Daniel Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event. The presentation is scheduled to conclude at

UPM Interim Report Q3 2022: UPM delivers all-time high quarterly results with excellent performance in all businesses

UPM-Kymmene Corporation        Stock Exchange Release (Interim Report)        25 October 2022 at 09:40 EEST UPM Interim Report Q3 2022:UPM delivers all-time high quarterly results with excellent performance in all businesses Q3 highlights · Sales increased by 36% to EUR 3,420 million (2,523 million in Q3 2021) · Comparable EBIT grew by 84% to EUR 779 million, 22.8% of sales (424 million, 16.8%) · Operating cash flow was EUR -201 million (318 million), impacted by cash flow from energy hedges. Other operating cash flows were largely as expected · The rise in energy

HC Andersen Capital Events 25/10: Meet the top management in OrderYOYO

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.OrderYOYO - Q3 trading updateLast week OrderYOYO announced its Q3 2022 trading update, implying that the company has reported its key financials and not a comprehensive financial report. Total ARR increased to DKK 185m (25% growth compared to consolidated Q3 2021 proforma numbers with app smart), meaning that OrderYOYO in Q3 has achieved the low end of the newly upgraded December 2022 ARR guidance of DKK 185-200m. OrderYOYO also highlights that

Alelion is planning for a higher order intake than expected for 2023

Current forecasts from Alelion's European customers confirm the contribution to a tremendous growth. A previously communicated order value of SEK 53 million over four years is now approaching an annual turnover of SEK 60 million as early as 2023.In previous communication, on June 8, 2021, Alelion communicated the company's largest order to date of SEK 53 million with deliveries planned over four years. A customized battery system has been developed for the customer's vehicle, which is used primarily in ports in a global market. Today, order placement has transitioned from individual orders

Realheart Featured in German TV Documentary

Press Release 25 October, 2022 Realheart's artificial heart is featured in a German TV documentary about heart disease and new scientific developments that will be broadcast on ZDF tonight, 25 October, at 8.15 PM.The documentary, entitled ''Horst Licther: Mein Herz, mein Motor'', follows a heart failure patient on the waiting list for a transplant. It also highlights the shortage of donor hearts and the need for new technology in artificial hearts. Both Realheart's founder Dr Azad Najar and Dr Dilek Gürsoy, who is part of the company's surgical team for the ongoing animal studies, are

AAK’s interim report for the third quarter 2022 – strong profit growth despite challenging macro-economic climate

AAK Group · Total volumes decreased by 4 percent, to 559,000 MT (583,000). · Operating profit, including a positive currency translation impact of SEK 148 million, increased by 28 percent, reaching SEK 822 million (642). At fixed foreign exchange rates, operating profit increased by 5 percent. · Profit for the period amounted to SEK 611 million (464). · Earnings per share amounted to SEK 2.36 (1.80). · Cash flow from operating activities amounted to negative SEK 40 million (negative 20). · Return on Capital Employed (ROCE), R12M, was 14.8 percent (15.6 at December 31,

Global sustainability actor Position Green chooses Varvsstaden in Malmö for new office and powerhouse

Position Green helps companies and organisations to develop their sustainability work and business within the ESG landscape. To meet the increasing demand and offer a meeting place in line with the company’s vision, Position Green is relocating its Malmö office to the new sustainable Varvsstaden district.Through a digital platform for all from collection to reporting of sustainability data, advisory and training services, Position Green helps companies and organisations to accelerate their sustainability transition. The company has grown rapidly and in line with the business sector’s ESG

Swedbank Robur backs CDP campaign asking big emitters to meet 1.5°C goal

Swedbank Robur is proud to join a group of 318 financial institutions and multinational firms with $37 trillion in assets and spending power in calling on over 1,000 of the world’s highest impact businesses to set emissions goals in line with the Paris agreement’s 1.5°C goal.The 2022 CDP Science-Based Targets campaign is coordinated by the global non-profit CDP organisation. By joining the campaign, Swedbank Robur is pressing the targeted companies to set an emissions reduction target approved through the Science Based Targets initiative the industry standard for credible climate targets

Investor presentation video release

On Wednesday 19 October 2022, LED iBond’s CEO Martin Løbel participated in an investor presentation followed by a Q&A session from the audience.The presentation was recorded, and a replay can be accessed here: https://www.youtube.com/watch?v=66hcvoDMUi4 The subscription period for the rights issue in LED iBond International A/S started Monday October 17, and runs until October 28. An investment brochure has been published and is available on the following link:https://ledibond.com/wp-content/uploads/2022/10/LED-iBond-Investment-Brochure.pdf The timeline of the rights issue is as

BioStock: Go-ahead for Lipum’s study – CMO comments

Lipum’s clinical trial application was recently approved by the regulatory authorities in the Netherlands, which means that the clinical phase I study with SOL-116 can be initiated. This marks an important milestone where Lipum is transitioning from preclinical to clinical phase, says the company’s CMO Helena Bergström in an interview with BioStock.Read the full article at biostock.se:https://www.biostock.se/en/2022/10/go-ahead-for-lipums-study-cmo-comments/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Nordic Capital completes one of the largest fundraises in Europe this year, closing Nordic Capital Fund XI at EUR 9 billion hard cap

· Nordic Capital’s eleventh large cap fund is the largest fund raised in the firm’s history, over 45% larger than its predecessor  · Strong demand from a globally diversified base of new and returning investors attracted to Nordic Capital’s investment strategy and strong portfolio performance and track recordNordic Capital today announced the completion of its largest ever fund raise with the successful closing of Nordic Capital Fund XI (“the Fund”) at its hard cap of EUR 9 billion, exceeding its EUR 8 billion target. The Fund, one of the largest and fastest private equity funds to be

Össur hf: Össur Temporarily Pauses Share Buybacks

Announcement no. 62/2022 25 October 2022 On 10 October 2022, Össur hf. initiated a share buyback program (“Program”), see Company Announcement no. 57/2022. The purpose of the Program is to reduce the Company’s share capital and adjust the capital structure by distributing capital to shareholders in line with the Company’s Capital Structure and Capital Allocation Policy. The Program will end no later than 30 September 2023, but the Company is entitled to stop the Program at any time. The Company may purchase up to 2,000,000 shares under the Program, corresponding to 0.47% of the

Helge Krogsbøl Succeeds Patrik Hall as Heimstaden’s CEO

Patrik Hall has after more than 20 years decided to leave his position and continue as Senior Advisor and member of the Group Investment Committee. Helge Krogsbøl, Heimstaden’s COO, takes over as CEO from 1 Jan 2023.“Patrik has been the key force in taking Heimstaden from a small Malmø based company, to today’s pan-European platform with more than 300,000 people living with us. Leaving the CEO position to Helge will give him the possibility to focus on investors and strategic investments, where his long experience and knowledge will play an important role. For a customer centred company

Helge Krogsbøl Succeeds Patrik Hall as Heimstaden’s CEO

Patrik Hall has after more than 20 years decided to leave his position and continue as Senior Advisor and member of the Group Investment Committee. Helge Krogsbøl, Heimstaden’s COO, takes over as CEO from 1 Jan 2023.“Patrik has been the key force in taking Heimstaden from a small Malmø based company, to today’s pan-European platform with more than 300,000 people living with us. Leaving the CEO position to Helge will give him the possibility to focus on investors and strategic investments, where his long experience and knowledge will play an important role. For a customer centred company

NOTICE OF EXTRA ORDINARY GENERAL MEETING IN MIDSONA AB (PUBL)

The shareholders in Midsona AB (publ), reg.no 556241-5322, (“Midsona”) are hereby given notice to the Extraordinary General Meeting that will be held on Thursday 24 November 2022. The Board has resolved that the Extraordinary General Meeting will be held without physical presence of shareholders, proxies or external parties and that the exercise of voting rights may only be made via post before the Meeting in accordance with the Swedish Act (2022:121) on temporary exceptions to facilitate the execution of general meetings in companies and other associations.Information about the

Charlotte Bergqvist är Årets kraftkvinna

Charlotte Bergqvist, Utvecklingschef på Cloudberry, har utsetts till Årets kraftkvinna i konkurrens med 139 andra framstående kvinnor i energibranschen.Priset delas varje år ut i syfte att lyfta förebilder i branschen och synliggöra kompetenta kvinnor för att locka fler till den. Enligt juryns motivering tilldelas Charlotte årets pris eftersom ”Oavsett om det har varit som grundare, vd, genom styrelseuppdrag eller som talare i de stora sammanhangen, har Charlotte alltid varit en förebild som fått människor och organisationer att växa och bidra till en hållbar, jämställd morgondag”. "Vi

Ahlsell continues to invest in Hallsberg Logistics Centre

Ahlsell has decided to make another significant investment in its Swedish logistics centre in Hallsberg. The move is prompted by confidence in the future and further growth ambitions. Expansion work is due to begin shortly via the establishment of a new site in the vicinity of our existing logistics building.Ahlsell’s logistics centre in Hallsberg is the heart of the Group’s Swedish operations. It is one of the largest of its kind in Europe and also one of the most important transport hubs in the Nordic region. The facility has an area of approximately 235,000 square metres and with 1,000

Interim information January–September 2022

This interim information for the period January–September 2022 has been prepared for the purpose of complying with the terms of Corem Kelly AB’s (publ) bond and loan agreements. On 29 March 2021, Corem Property Group AB (publ) announced a public offer to the shareholders of Klövern AB (publ). In June 2021, the offer was declared unconditional, after which Klövern's shares were delisted from Nasdaq Stockholm in July 2021. Following a resolution at the Annual General Meeting on 27 April 2022 Klövern AB has been renamed Corem Kelly AB.   JANUARY–SEPTEMBER 2022   •

Update on MESSINA Phase III trial

25 October 2022 07:00 BST Update on the MESSINA Phase III trial for Fasenra in eosinophilic esophagitis MESSINA did not meet one of the two dual-primary endpoints, demonstrating a statistically significant improvement in histological disease remission with Fasenra, but not in dysphagia symptoms, compared to placebo Eosinophilic esophagitis (EoE) is a rare, progressive, chronic inflammatory disease of the esophagus currently believed to be characterised by the abnormal presence of eosinophils, a type of white blood cell, in the inner lining of the esophagus.[1-3] Patients experience

Relais Group Plc has decided on the transition to IFRS reporting

Relais Group Plc, Company release 25 October 2022 at 9.00 a.m. EEST Relais Group Plc has decided on the transition from Finnish Accounting Standards (FAS) to apply the International Financial Reporting Standards (IFRS) in its financial reporting. Relais Group Plc will publish its first Consolidated Financial Statements prepared in accordance with IFRS for the financial year ended 31 December 2021. Comparative financial information is presented for the financial year ended 31 December 2020 and the transition date for IFRS reporting is 1 January 2020. Relais Group Plc has previously

Interim Report January - September 2022

Continued strong growth and good profitabilityJuly – September 2022 · Revenues increased by 35.6 per cent to SEK 1,098.6 million (810.4).  · Adjusted EBITA increased by 30.9 per cent and amounted to SEK 78.3 million (59.8), corresponding to an adjusted EBITA margin of 7.1 per cent (7.4).  · Profit before tax amounted to SEK 56.1 million (46.9). · Profit after tax amounted to SEK 43.9 million (37.4). · Profit per share amounted to SEK 1.60 (1.36). · New contracts relating to cloud services worth SEK 158.1 million (74.8) were contracted, an increase by 111.5 per cent. ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top